Prospective study of fibrosis in the lung endpoints (PROFILE): characteristics of an incident cohort of patients with idiopathic pulmonary fibrosis
The PROFILE cohort confirms that untreated IPF is inexorably progressive and inevitably fatal with a poor median survival from diagnosis.
Authors
- Iain D. Stewart (ORCID: https://orcid.org/0000-0002-1340-2688)
- Philip L. Molyneaux (ORCID: https://orcid.org/0000-0003-1301-8800)
- Gauri Sachiko Saini
- Gisli Jenkins
- Toby Maher
Institutions
- University of Leicester (GB)
- GlaxoSmithKline (United Kingdom) (GB)
- Royal Papworth Hospital (GB)
- Keck Hospital of USC (US)
- Nottingham City Hospital (GB)
- National Institute for Health and Care Research (GB)
- Stevenage Bioscience Catalyst (GB)
- Royal Brompton Hospital (GB)
- Lung Institute (US)
- NIHR Imperial Biomedical Research Centre (GB)
- Nottingham Biomedical Research Centre (GB)
- NIHR Leicester Biomedical Research Centre (GB)
Publication Details
- Journal
- BMJ Open Respiratory Research
- Published
- 2026-01-01
- DOI
- https://doi.org/10.1136/bmjresp-2025-003763
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- GlaxoSmithKline
- National Institute for Health and Care Research
- Medical Research Council
- NIHR Imperial Biomedical Research Centre
- NIHR Nottingham Biomedical Research Centre